Excessive amounts of ototoxic agents, such as cisplatin and aminoglycoside antibiotics, usually induce hair cell death and permanent sensorineural hearing loss. They generate reactive oxygen species (ROS) in the cochlea, which activate several kinase pathways, including c-Jun-N-terminal kinase, p38 mitogen-activated protein kinase, and protein kinase B (AKT). These kinase pathways function as damaging or protecting mechanisms in ototoxicity. Sphingolipid metabolites, including ceramide, sphingosine, and their phosphorylates (ceramide-1-phosphonate [C1P] and sphingosine-1-phosphate [S1P]), are well-known regulators of diverse cellular processes, including apoptosis, cell cycle, and cellular differentiation. This review summarizes the roles of sphingolipid mediators in cochlear ototoxicity.
Two pathways are known to generate ceramide: the de novo ceramide synthetic pathway and the sphingomyelinase pathway (ceramide/sphingomyelin cycle). Ototoxic agents activate sphingomyelinase, and ceramide is mainly generated via activated sphingomyelinase in the cochlea through a ceramide/sphingomyelin cycle from sphingomyelin. The generated ceramide is converted to other sphingolipid mediators. Ceramide and sphingosine accelerate the cochlear hair cell death induced by ototoxic agents. Conversely, C1P and S1P inhibit cochlear hair cell death. S1P receptor subtype 2 is involved in the hair-cell protection effect of S1P. C1P and S1P activate AKT, which inhibits the cochlear hair cell death induced by ototoxic agents.
In conclusion, sphingolipid mediators are generated in response to ototoxic agents and play important roles in determining the fate of cochlear hair cells in ototoxic injury.
View full abstract